Cardio Diagnostics Holdings (CDIO) Current Leases (2023 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Current Leases of $199854.0 for Q1 2026, down 15.89% sequentially from $237607.0 in Q4 2025, and down 16.97% YoY from $240707.0 in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Current Leases (2023 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Current Leases for 4 years, with the latest figure at $199854.0 in Q1 2026.
- Quarterly Current Leases fell 16.97% year-over-year to $199854.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199854.0 (down 16.97% YoY) and the FY2025 annual result came in at $237607.0, changed 0.14% from the prior year.
- Current Leases retreated to $199854.0 in Q1 2026 per CDIO's latest filing, from $237607.0 in the prior quarter.
- Over five years, Current Leases peaked at $247714.0 in Q3 2025 and troughed at $178066.0 in Q3 2023.
- A 4-year average of $227356.2 and a median of $233871.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2026: Current Leases surged 31.34% in 2024, then slipped 16.97% in 2026.
- Over 4 years, Current Leases stood at $223929.0 in 2023, then rose by 5.96% to $237270.0 in 2024, then climbed by 0.14% to $237607.0 in 2025, then slipped by 15.89% to $199854.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $199854.0, $237607.0, and $247714.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Cardio Diagnostics Holdings | 6.03 Mn | 443,812.80 | - | 161,667.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 161,667.00 |
| Mar 31, 2026 | 199,854.00 |
| Dec 31, 2025 | 237,607.00 |
| Sep 30, 2025 | 247,714.00 |
| Jun 30, 2025 | 244,182.00 |
| Mar 31, 2025 | 240,707.00 |
| Dec 31, 2024 | 237,270.00 |
| Sep 30, 2024 | 233,871.00 |
| Jun 30, 2024 | 230,515.00 |
| Mar 31, 2024 | 227,203.00 |
| Dec 31, 2023 | 223,929.00 |
| Sep 30, 2023 | 178,066.00 |